Your browser doesn't support javascript.
loading
Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.
Altabás-González, Irene; Rua-Figueroa, Iñigo; Mouriño, Coral; Roberts, Karen; Jimenez, Norman; Martinez-Barrio, Julia; Galindo, María; Calvo Alén, Jaime; Pérez, Victor Del Campo; Uriarte Itzazelaia, Esther; Tomero, Eva; Freire-González, Mercedes; Martínez Taboada, Víctor; Salgado, Eva; Vela, Paloma; Fernandez-Nebro, Antonio; Olivé, Alejandro; Narváez, Javier; Menor-Almagro, Raúl; Soler, Gregorio Santos; Hernández-Beriain, José Ángel; Manero, Javier; Aurrecoechea, Elena; Ibarguengoitia-Barrena, Oihane; Montilla, Carlos; Bonilla, Gema; Torrente-Segarra, Vicenç; Cacheda, Ana Paula; García-Villanueva, María Jesús; Moriano-Morales, Claudia; Manteca, Concepción Fito; Lozano-Rivas, Nuria; Bohórquez, Cristina; Pego-Reigosa, José M.
Afiliação
  • Altabás-González I; Rheumatology Department, Vigo University Hospital Group, Vigo, Spain.
  • Rua-Figueroa I; IRIDIS Group (Investigation in Rheumatology and Immune-Diseases), Galicia Sur Health Research Institute, Vigo, Spain.
  • Mouriño C; Rheumatology, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain iruafer@gobiernodecanarias.org.
  • Roberts K; Rheumatology Department, Vigo University Hospital Group, Vigo, Spain.
  • Jimenez N; Rheumatology, Instituto de Investigación, Galicia Sur, External Statistical Advisor, Rosario, Argentina.
  • Martinez-Barrio J; IRIDIS Group (Investigation in Rheumatology and Immune-Diseases), Galicia Sur Health Research Institute, Vigo, Spain.
  • Galindo M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Calvo Alén J; Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
  • Pérez VDC; Rheumatology, Hospital Universitario Araba, Vitoria-Gasteiz, Spain.
  • Uriarte Itzazelaia E; IRIDIS Group (Investigation in Rheumatology and Immune-Diseases), Galicia Sur Health Research Institute, Vigo, Spain.
  • Tomero E; Department of Epidemiology, Vigo University Hospital Group, Vigo, Spain.
  • Freire-González M; Department of Rheumatology, Donostia University Hospital Gipuzkoa Building, San Sebastian, Spain.
  • Martínez Taboada V; Rheumatology Department, Hospital Universitario de la Princesa, Madrid, Spain.
  • Salgado E; Rheumatology, Academic Hospital Juan Canalejo de La Coruña Cardiology Service, A Coruna, Spain.
  • Vela P; Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Fernandez-Nebro A; Rheumatology, Complejo Hospitalario de Orense, Ourense, Spain.
  • Olivé A; Department of Rheumatology, Hospital General Universitario de Alicante, Alicante, Spain.
  • Narváez J; Rheumatology, Hospital Regional Universitario de Málaga, Malaga, Spain.
  • Menor-Almagro R; Rheumatology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Spain.
  • Soler GS; Rheumatology, Hospital Universitario de Bellvitge, Hospitalet de LLobregat, Spain.
  • Hernández-Beriain JÁ; Rheumatology Service, Jerez Hospital, Jerez, Spain.
  • Manero J; Department of Rheumatology, Hospital Villajoyosa, Alicante, Spain.
  • Aurrecoechea E; Rheumatology, Hospital Insular of Gran Canaria, Gran Canaria, Spain.
  • Ibarguengoitia-Barrena O; Department of Rheumatology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Montilla C; Rheumatology, Hospital Sierrallana, Torrelavega, Spain.
  • Bonilla G; Rheumatology Department, Hospital Universitario de Basurto, Bilbao, Spain.
  • Torrente-Segarra V; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Cacheda AP; Rheumatology, La Paz University Hospital, Madrid, Spain.
  • García-Villanueva MJ; Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despi, Spain.
  • Moriano-Morales C; Department of Rheumatology, Hospital Son Llatzer, Palma de Mallorca, Spain.
  • Manteca CF; Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Lozano-Rivas N; Department of Rheumatology, Hospital de León, León, Spain.
  • Bohórquez C; Department of Rheumatology, Universidad de Navarra-Campus Universitario, Pamplona, Spain.
  • Pego-Reigosa JM; Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain.
Lupus Sci Med ; 11(2)2024 Aug 03.
Article em En | MEDLINE | ID: mdl-39097409
ABSTRACT

OBJECTIVE:

To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.

METHODS:

Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded.

RESULTS:

During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering 'cerebrovascular accident' and 'claudication for 6 months' as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20-25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI.

CONCLUSIONS:

New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Sistema de Registros / Lúpus Eritematoso Sistêmico Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lupus Sci Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Sistema de Registros / Lúpus Eritematoso Sistêmico Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lupus Sci Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido